Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Role of aldose reductase(AR) and matrix metalloproteinases(MMP) in the development of diabetic atherosclerosis

FY 2009-10

Summary
Cardiovascular diseases such as atherosclerosis are the major cause of morbidity and mortality in diabetes and affects millions of people in Canada and worldwide. The lack of specific treatments for these diseases arises partly due to a poor understanding of the underlying molecular mechanisms. We recently discovered that high blood glucose per se could accelerate the development of atherosclerosis in diabetic mice. We found that this involves aldose reductase (AR), an enzyme that converts glucose to sorbitol (and finally to fructose by sorbitol dehydrogenase) and by depleting glutathione levels (antioxidant that normally protects cells from free radical induced damage). As a result this leads to an increase in cellular oxidative stress and greater atherosclerosis. However, the mechanisms are still unclear. We have found evidence (unpublished data) that high fructose diet would cause blood vessel to function abnormally by activating an enzyme system called, matrix metalloproteinases (MMP). Abnormal blood vessel function may eventually lead to atherosclerosis. Our main objective is to determine whether AR exacerbates the atherosclerotic process in diabetes by activating MMPs via oxidative stress and to determine the mechanisms involved there in. Specifically, we will study how overexpression of AR, the enzyme that produces excessive oxidative stress by utilizing glucose will affect the function of normal and diabetic blood vessels. This project will provide insights into how blood vessels function in diabetes and the mechanisms that are directly relevant to the development of vascular diseases such as atherosclerosis. The results of our study could facilitate the discovery of unique drug targets for treatment of diabetic vascular disease.
Program
CIHR Fellowship
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
193186
Name
Nagareddy Prabhakara Redd
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of aldose reductase(AR) and matrix metalloproteinases(MMP) in the development of diabetic atherosclerosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Aldose Reductase; Atherosclerosis; Diabetes; Endothelium; Fructose; Glutathione; Matrix Metalloproteinase; Oxidative Stress; Transgenic Mice; Vascular Disease
Abstract
Cardiovascular diseases such as atherosclerosis are the major cause of morbidity and mortality in diabetes and affects millions of people in Canada and worldwide. The lack of specific treatments for these diseases arises partly due to a poor understanding of the underlying molecular mechanisms. We recently discovered that high blood glucose per se could accelerate the development of atherosclerosis in diabetic mice. We found that this involves aldose reductase (AR), an enzyme that converts glucose to sorbitol (and finally to fructose by sorbitol dehydrogenase) and by depleting glutathione levels (antioxidant that normally protects cells from free radical induced damage). As a result this leads to an increase in cellular oxidative stress and greater atherosclerosis. However, the mechanisms are still unclear. We have found evidence (unpublished data) that high fructose diet would cause blood vessel to function abnormally by activating an enzyme system called, matrix metalloproteinases (MMP). Abnormal blood vessel function may eventually lead to atherosclerosis. Our main objective is to determine whether AR exacerbates the atherosclerotic process in diabetes by activating MMPs via oxidative stress and to determine the mechanisms involved there in. Specifically, we will study how overexpression of AR, the enzyme that produces excessive oxidative stress by utilizing glucose will affect the function of normal and diabetic blood vessels. This project will provide insights into how blood vessels function in diabetes and the mechanisms that are directly relevant to the development of vascular diseases such as atherosclerosis. The results of our study could facilitate the discovery of unique drug targets for treatment of diabetic vascular disease.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nagareddy, Prabhakara Redd
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2009-10) | Canada Spends